Berenberg Bank reiterated their buy rating on shares of Siemens Healthineers (OTCMKTS:SMMNY) in a research note issued to investors on Tuesday morning, The Fly reports.
Several other equities research analysts have also commented on the company. Jefferies Financial Group started coverage on Siemens Healthineers in a research note on Wednesday, September 8th. They issued a hold rating for the company. UBS Group restated a neutral rating on shares of Siemens Healthineers in a research note on Wednesday, October 13th. JPMorgan Chase & Co. restated an overweight rating on shares of Siemens Healthineers in a research note on Thursday, November 18th. Barclays restated an equal weight rating on shares of Siemens Healthineers in a research note on Friday, September 10th. Finally, Societe Generale lowered Siemens Healthineers from a buy rating to a hold rating in a research note on Friday, October 1st. One analyst has rated the stock with a sell rating, five have issued a hold rating and nine have issued a buy rating to the company. According to data from MarketBeat.com, Siemens Healthineers currently has a consensus rating of Buy.
Shares of SMMNY opened at $35.62 on Tuesday. Siemens Healthineers has a 1-year low of $22.32 and a 1-year high of $37.77. The firm has a fifty day simple moving average of $34.08 and a two-hundred day simple moving average of $32.32.
Siemens Healthineers AG operates as a holding company. The company intends to operate the digital services business. It operates through the following business segments: Imaging, Diagnotics, and Advanced Therapies. The Imaging segment offers diagnostic imaging products and a broad portfolio of advanced imaging and ultrasound systems and solutions.
Receive News & Ratings for Siemens Healthineers Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Siemens Healthineers and related companies with MarketBeat.com's FREE daily email newsletter.